• Wed. May 5th, 2021

Prevention & Cures

Well-Being.Medical Advances Mental Health. Longevity. Prevention & Cures.

COVID-19 Vaccine | Novel Coronavirus (COVID-19) – coronavirus.idaho.gov

By

Dec 5, 2020

Page last updated on December 4th, 2020 at 03:27 pm

Idaho’s COVID-19 Vaccine Advisory Committee (CVAC) discusses recommendations for sub-priority tiers in each phase of COVID-19 vaccination to advise the Governor. Sub-prioritization in Idaho for each phase is voted on by CVAC and a final decision is made by the Governor. As final approval is given to the priority populations, the determinations will be released to the public.

COMING SOON: The state is working with public health districts, hospitals, Federally Qualified Health Centers, and other facilities who will be receiving and administering early vaccine doses. Information about how to obtain a vaccine will be forthcoming.

COVID-19 vaccination can help keep you from getting COVID-19. COVID-19 vaccines are being carefully evaluated in clinical trials and will be authorized or approved only if they are shown to be safe and effective in reducing your chances of getting COVID-19. Based on what we know about vaccines for other diseases, experts believe that getting a COVID-19 vaccine may help keep you from getting seriously ill even if you do get COVID-19. Getting vaccinated yourself may also protect people around you, particularly people at increased risk for severe illness from COVID-19.

COVID-19 vaccination will be an important tool to help stop the COVID-19 pandemic. Wearing masks and social distancing help reduce your chance of being exposed to the virus or spreading it to others, but these measures are difficult to maintain for long periods of time. Vaccines will work with your immune system so it will be ready to fight the virus if you are exposed.

  • December 10: Food and Drug Administration’s (FDA) Vaccine Advisory Board meets to review the clinical trial data on Pfizer vaccine and will make a recommendation on whether to grant the Emergency Use Authorization (EUA).
  • December 17: FDA’s Vaccine Advisory Board meets to review the clinical trial data on Moderna vaccine and will make a recommendation on whether to grant the EUA.
  • December 18: CVAC Meeting

Future ACIP meetings will be scheduled based on EUA approvals.

 

Loading ....

Leave a Reply

Your email address will not be published. Required fields are marked *